Back

Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book

European Heart Journal

4 November 2022
Organised by: Logo
Read full article
ESC Journals PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Raul D Santos
Raul D Santos

Author

Viviane Z Rocha
Viviane Z Rocha

Author

You may be interested in
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients
3 April 2025
thumbnail
Congress Presentation
An epigenetic editor targeting human PCSK9 efficiently and durably lowers Low Density Lipoprotein Cholesterol (LDL-C) in non-human primates
2 September 2024
thumbnail
Webinar
How to treat patients with borderline dyslipidemia
8 February 2023
thumbnail
Practice Tools
How to manage blood cholesterol in primary and secondary prevention
16 May 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources